CN114621121A - Preparation method of camphor sulfonyl hydrazine compound, product and application thereof - Google Patents

Preparation method of camphor sulfonyl hydrazine compound, product and application thereof Download PDF

Info

Publication number
CN114621121A
CN114621121A CN202210264700.6A CN202210264700A CN114621121A CN 114621121 A CN114621121 A CN 114621121A CN 202210264700 A CN202210264700 A CN 202210264700A CN 114621121 A CN114621121 A CN 114621121A
Authority
CN
China
Prior art keywords
camphorsulfonyl
chloride
compound
preparation
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202210264700.6A
Other languages
Chinese (zh)
Other versions
CN114621121B (en
Inventor
谷文
杨子辉
孙雪宝
金道峻
邱遗贵
王石发
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Forestry University
Original Assignee
Nanjing Forestry University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Forestry University filed Critical Nanjing Forestry University
Priority to CN202210264700.6A priority Critical patent/CN114621121B/en
Publication of CN114621121A publication Critical patent/CN114621121A/en
Application granted granted Critical
Publication of CN114621121B publication Critical patent/CN114621121B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/48Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups having nitrogen atoms of sulfonamide groups further bound to another hetero atom
    • C07C311/49Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups having nitrogen atoms of sulfonamide groups further bound to another hetero atom to nitrogen atoms
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N41/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom
    • A01N41/02Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom containing a sulfur-to-oxygen double bond
    • A01N41/04Sulfonic acids; Derivatives thereof
    • A01N41/06Sulfonic acid amides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/38Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reaction of ammonia or amines with sulfonic acids, or with esters, anhydrides, or halides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/76Nitrogen atoms to which a second hetero atom is attached
    • C07D213/77Hydrazine radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/36Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/42Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses a preparation method of camphor sulfonyl hydrazide compounds, products and application thereof, wherein the structural formula of the camphor sulfonyl hydrazide compounds is as follows:
Figure DDA0003551204710000011
the camphor sulfonyl hydrazide compound is applied to preventing and treating plant fungi in agriculture or forestry, and the activity result shows that: the compound provided by the invention has better control effects on wheat scab, phytophthora capsici and hickory nut dry rot.

Description

Preparation method of camphor sulfonyl hydrazine compound, product and application thereof
Technical Field
The invention belongs to the technical field of pesticide synthesis, and particularly relates to a preparation method of camphor sulfonyl hydrazine compounds, products and application thereof.
Background
Wheat scab is a major disease that compromises wheat growth. Wheat scab can cause seedling withering, ear rot, stem rot, stalk rot and ear rot, and the seedling can be damaged from seedling to ear emergence and needs to be prevented and treated in time.
The wheat scab control method comprises the following steps:
(1) selecting disease-resistant varieties: at present, although immune varieties are not found, some disease-resistant varieties with good agronomic characters exist, such as Sumai No. 3 and Sumai No. 2. Spring wheat includes Dingfeng No. 3 and Ningchun No. 24. Each place can be selected according to the local conditions.
(2) Agricultural control: reasonable irrigation and drainage, and ditches are required to be dug in the wetland for drainage. Deep ploughing and stubble cleaning are needed after harvesting, and the bacteria source is reduced. Timely seeding is carried out, and rain in the flowering period is avoided. The compost made by retting enzyme bacteria is advocated, a formula fertilization technology is adopted, and when fertilization is performed, nitrogen fertilizer is forbidden to be applied partially, so that the disease resistance of plants is improved.
On the other hand, in recent years, researches on terpenoids have attracted much attention in the medical or agricultural fields, and camphor, an important resource of forest products, is a non-woody forest product with a bicyclic monoterpene structure, naturally exists in Lauraceae plants, is a renewable natural dominant biomass resource in China, and has an IUPAC name of 1,7, 7-trimethylbicyclo [2.2.1 ] being a 1,7, 7-trimethylbicyclo]Heptane-2-one of formula C10H16And O. It is white or transparent waxy solid at room temperature, and can be used for repelling insects. The camphor is extracted from camphor tree trunks, and the camphor trees with the older ages are rich in camphor in a larger proportion. The refining method comprises cutting trunk into small pieces, distilling with water, heating oleum Camphora, rising with water vapor, and cooling in a pottery jar placed above. The traditional Chinese medicine preparation mainly utilizes the effects of cooling, fragrance, dispersion and pain relief. It is often added in the form of rubber ointment, tincture, plaster, oil and ointment. Therefore, the camphor is widely applied to the fields of medical intermediates, environment-friendly mothproofing agents, spices, incense, industrial raw materials and the like。
The camphor from natural sources can not meet the expanding market demand of camphor due to the reasons of resource shortage, protection and the like, so the synthetic camphor produced by taking turpentine as raw material can be produced at the same time. Because the turpentine oil is rich in resources, the synthetic camphor and the natural camphor have no essential difference in the aspects of chemical properties, application performance and the like, and the synthetic camphor can completely replace the natural camphor for use.
The preparation method of the camphor sulfonyl hydrazide compound and the application in sterilization are not reported.
Disclosure of Invention
This section is for the purpose of summarizing some aspects of embodiments of the invention and to briefly introduce some preferred embodiments. In this section, as well as in the abstract and the title of the invention of this application, simplifications or omissions may be made to avoid obscuring the purpose of the section, the abstract and the title, and such simplifications or omissions are not intended to limit the scope of the invention.
The present invention has been made keeping in mind the above and/or other problems occurring in the prior art.
Therefore, the object of the present invention is to overcome the disadvantages of the prior art and to provide camphorsulfonylhydrazide compounds.
In order to solve the technical problems, the invention provides the following technical scheme: the camphor sulfonyl hydrazide compound has the structural formula shown as follows:
Figure BDA0003551204690000021
wherein,
Figure BDA0003551204690000022
it is still another object of the present invention to provide a method for preparing camphorsulfonylhydrazide compounds, which overcomes the disadvantages of the prior art.
In order to solve the technical problems, the invention provides the following technical scheme: the preparation method of the camphor sulfonyl hydrazine compound comprises the steps of reacting L-10-camphor sulfonic acid with thionyl chloride to synthesize an L-10-camphor sulfonyl chloride intermediate;
reacting the L-10-camphorsulfonyl chloride intermediate with substituted phenylhydrazine hydrochloride, triethylamine and 4-dimethylamino pyridine to synthesize camphorsulfonyl hydrazide compounds I-1 to I-18;
the L-10-camphorsulfonyl chloride intermediate reacts with 1-naphthylhydrazine hydrochloride, triethylamine and 4-dimethylamino pyridine to synthesize the camphorsulfonyl hydrazide compound I-19.
As a preferable embodiment of the preparation method of the camphor sulfonyl hydrazide compound, the preparation method comprises the following steps: an intermediate of L-10-camphorsulfonyl chloride, a process for its preparation, comprising,
adding 3.0mmol of L-10-camphorsulfonic acid and 3.3mmol of thionyl chloride into a single-mouth bottle, heating to reflux temperature, reacting for 5 hours, cooling, concentrating and removing most of solvent and HCl to obtain white solid L-10-camphorsulfonyl chloride.
As a preferable embodiment of the preparation method of the camphor sulfonyl hydrazide compound, the preparation method comprises the following steps: the feeding molar ratio of the intermediate L-10-camphorsulfonyl chloride to the substituted phenylhydrazine hydrochloride is 1.1: 1.
As a preferable embodiment of the preparation method of the camphor sulfonyl hydrazide compound, the preparation method comprises the following steps: the feeding molar ratio of the substituted phenylhydrazine hydrochloride to the triethylamine is 1: 1.1.
As a preferable embodiment of the preparation method of the camphor sulfonyl hydrazide compound, the preparation method comprises the following steps: the molar ratio of the L-10-camphorsulfonyl chloride intermediate to 4-dimethylaminopyridine was 1.1: 0.1.
As a preferable embodiment of the preparation method of the camphor sulfonyl hydrazide compound, the preparation method comprises the following steps: synthesizing camphor sulfonyl hydrazide compounds I-1-I-18, wherein the synthesis reaction temperature is 25 ℃, and the reaction time is 5-10 h; the camphor sulfonyl hydrazine compound I-19 is synthesized by reaction, the reaction temperature is 25 ℃, and the reaction time is 5-10 h.
As a preferable embodiment of the preparation method of the camphor sulfonyl hydrazide compound, the preparation method comprises the following steps: the feeding molar ratio of the intermediate L-10-camphorsulfonyl chloride to the 1-naphthylhydrazine hydrochloride is 1.1: 1.
The invention also aims to overcome the defects in the prior art and provide the application of the camphor sulfonyl hydrazine compounds in preventing and controlling plant fungi in agriculture or forestry, wherein the plant fungi comprise wheat scab, phytophthora capsici and hickory nut stem rot.
The invention has the beneficial effects that:
(1) the camphor sulfonyl hydrazide compound has a novel molecular structure, and is a novel compound; the chemical structure is characterized in that the chemical structure is clear, the structural formula contains sulfonyl hydrazide, wherein a substituted benzene (naphthalene) group is connected with camphorsulfonic acid through sulfonyl hydrazide bonds; the preparation method of the compound is simple and convenient, the raw materials are easy to obtain, the reaction conditions are easy to control, and particularly in the step of synthesizing the camphor sulfonyl hydrazine compound, the product can be obtained through column chromatography.
(2) The compound of the invention is a medicament for preventing and treating plant fungi in the agricultural or forestry field, and the medicament has better prevention and treatment effects on wheat scab, phytophthora capsici leonian and hickory nut stem rot.
Drawings
In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the drawings needed to be used in the description of the embodiments will be briefly introduced below, and it is obvious that the drawings in the following description are only some embodiments of the present invention, and it is obvious for those skilled in the art to obtain other drawings based on these drawings without inventive exercise. Wherein:
FIG. 1 is a schematic diagram of preparation methods of camphorsulfonyl hydrazide compounds I-1 to I-18 in the embodiment of the invention.
FIG. 2 is a schematic diagram showing a process for producing a camphorsulfonyl hydrazide compound I-19 in an example of the present invention.
FIG. 3 is a schematic diagram of the in vitro assay (plate) of Compound I-11 against Gibberella zeae in the present example (from left to right concentrations of 0.781mg/L,0.195mg/L,0.049mg/L,0.012mg/L and 0.003mg/L, respectively).
Detailed Description
In order to make the aforementioned objects, features and advantages of the present invention more comprehensible, specific embodiments thereof are described in detail below with reference to examples of the specification.
In the following description, numerous specific details are set forth in order to provide a thorough understanding of the present invention, however, the present invention may be practiced otherwise than as specifically described herein, and it will be appreciated by those skilled in the art that the present invention may be practiced without departing from the spirit and scope of the present invention and that the present invention is not limited by the specific embodiments disclosed below.
Furthermore, reference herein to "one embodiment" or "an embodiment" means that a particular feature, structure, or characteristic described in connection with the embodiment is included in at least one implementation of the invention. The appearances of the phrase "in one embodiment" in various places in the specification are not necessarily all referring to the same embodiment, nor are separate or alternative embodiments mutually exclusive of other embodiments.
Dissolving substituted phenylhydrazine hydrochloride (1.0mmol), 4-dimethylaminopyridine (0.1mmol) and triethylamine (1.1mmol) in anhydrous dichloromethane, cooling to 0 ℃, adding L-10-camphorsulfonyl chloride (1.1mol) in batches, raising the temperature to 25 ℃, and reacting for 5-10 h.
The TLC monitored the starting material reaction was complete, the organic layer was washed 3 times with water (8mL x 3), 3 times with saturated brine (8mL x 3), dried, filtered with suction, concentrated to remove dichloromethane, and the crude product was chromatographed (CH2Cl2: MeOH ═ 20:1) to give the target compounds I-1 to I-18. The preparation method of the camphor sulfonyl hydrazide compounds I-1 to I-18 is shown in figure 1.
In the invention, L-10-camphorsulfonic acid, 4-dimethylamino pyridine, triethylamine and substituted phenylhydrazine hydrochloride are all purchased from Shanghai Biao science and technology Limited; thionyl chloride was purchased from Tianjin polishing chemical plant; other raw materials are all common commercial products.
Example 1
Figure BDA0003551204690000051
Dissolving 2-chlorophenylhydrazine hydrochloride (1.0mmol), 4-dimethylaminopyridine (0.1mmol) and triethylamine (1.1mmol) in anhydrous dichloromethane, cooling to 0 deg.C, adding L-10-camphorsulfonyl chloride (1.1mol) in batches, and heating to room temperatureReacting at 25 deg.C for 5h, monitoring by TLC that the starting material has reacted completely, washing the organic layer with water 3 times (8 mL. times.3), washing with saturated saline 3 times (8 mL. times.3), drying, suction filtering, concentrating to remove dichloromethane, and subjecting the crude product to column Chromatography (CH)2Cl2MeOH ═ 20:1) to give the title compound I-1, white solid, m.p.150-151 ℃, yield: 60 percent.1H NMR(600MHz,CDCl3)δ7.38(dd,J=8.2,1.3Hz,1H),7.25(d,J=1.2Hz,1H),7.21(t,J=8.4Hz,2H),6.85–6.82(m,1H),6.45(s,1H),3.79(d,J=15.5Hz,1H),2.90(d,J=15.5Hz,1H),2.49–2.44(m,1H),2.35–2.30(m,1H),2.18(t,J=4.5Hz,1H),2.10–2.04(m,1H),1.99(J=18.8Hz,1H),1.89–1.84(m,1H),1.52–1.47(m,1H),1.03(s,3H),0.94(s,3H).13C NMR(150MHz,CDCl3)δ218.84,143.07,129.08,127.88,121.35,118.57,115.14,59.06,49.46,46.65,43.07,42.68,27.13,26.12,19.85,19.35.
Example 2
Figure BDA0003551204690000052
Dissolving 4-cyanophenylhydrazine hydrochloride (1.0mmol), 4-dimethylaminopyridine (0.1mmol) and triethylamine (1.1mmol) in anhydrous dichloromethane, cooling to 0 ℃, adding L-10-camphorsulfonyl chloride (1.1mol) in batches, raising the temperature to 25 ℃, reacting for 5.5h, monitoring the completion of the reaction of the raw materials by TLC, washing an organic layer with water for 3 times (8mL x 3), washing with saturated saline water for 3 times (8mL x 3), drying, performing suction filtration, concentrating to remove dichloromethane, and performing column chromatography on a crude product (CH)2Cl2MeOH ═ 20:1) gave the title compound I-2, a brown solid, m.p.97-99.5 ℃ in 65% yield.1H NMR(600MHz,CDCl3)δ7.52(d,J=8.2Hz,2H),7.06(d,J=8.4Hz,2H),6.50(s,1H),3.68(d,J=15.4Hz,1H),2.90(d,J=15.4Hz,1H),2.48–2.44(m,1H),2.36–2.31(m,1H),2.20(t,J=4.4Hz,1H),2.11–2.06(m,1H),2.00(d,J=18.9Hz,1H),1.84–1.80(m,2H),1.53–1.49(m,1H),1.04(s,3H),0.93(s,3H).13C NMR(150MHz,CDCl3)δ219.30,150.67,133.59,119.57,113.36,103.28,59.03,49.57,46.89,43.06,42.59,27.07,25.92,19.85,19.29.
Example 3
Figure BDA0003551204690000061
Dissolving 4-trifluoromethylphenylhydrazine hydrochloride (1.0mmol), 4-dimethylaminopyridine (0.1mmol) and triethylamine (1.1mmol) in anhydrous dichloromethane, cooling to 0 ℃, adding L-10-camphorsulfonyl chloride (1.1mol) in batches, raising the temperature to 25 ℃, reacting for 6h, monitoring the completion of the reaction of the raw materials by TLC, washing an organic layer with water for 3 times (8mL x 3), washing with saturated saline solution for 3 times (8mL x 3), drying, performing suction filtration, concentrating to remove dichloromethane, and performing column chromatography on a crude product (CH)2Cl2MeOH ═ 20:1) gave the title compound I-3, a pale yellow solid, m.p.143-144 ℃, yield 67%.1H NMR(600MHz,CDCl3)δ7.49(d,J=8.5Hz,2H),7.09(d,J=8.5Hz,2H),6.90(s,1H),6.44(s,1H),3.70(d,J=15.5Hz,1H),2.90(d,J=15.5Hz,1H),2.51–2.41(m,1H),2.37–2.29(m,1H),2.19(t,J=4.5Hz,1H),2.11–2.05(m,1H),1.99(d,J=18.8Hz,1H),1.86–1.81(m,1H),1.52–1.48(m,1H),1.03(s,3H),0.93(s,3H).13C NMR(150MHz,CDCl3)δ218.94,149.85(d,J=5.3Hz),126.47(t,J=4.8Hz),124.49(q,J=269.7Hz),122.85(q,J=31.8Hz),121.64,113.09,59.01,49.42,46.81,43.02,42.60,27.04,25.96,19.79,19.29.
Example 4
Figure BDA0003551204690000071
Dissolving 4-nitrophenylhydrazine hydrochloride (1.0mmol), 4-dimethylaminopyridine (0.1mmol) and triethylamine (1.1mmol) in anhydrous dichloromethane, cooling to 0 ℃, adding L-10-camphorsulfonyl chloride (1.1mol) in batches, raising the temperature to 25 ℃, reacting for 8h, monitoring the completion of the reaction of raw materials by TLC, washing an organic layer with water for 3 times (8mL x 3), washing with saturated saline solution for 3 times (8mL x 3), drying, performing suction filtration, concentrating to remove dichloromethane, and performing column chromatography on a crude product (CH)2Cl2MeOH ═ 20:1) gave the title compound I-4, a pale yellow solid, m.p.140.7-141 ℃ in 30.1% yield.1H NMR(600MHz,CDCl3)δ8.13(d,J=9.2Hz,2H),7.55–7.29(m,1H),7.05(d,J=9.2Hz,2H),6.62(s,1H),3.68(d,J=15.5Hz,1H),2.92(d,J=15.5Hz,1H),2.48–2.44(m,1H),2.36–2.31(m,1H),2.20(t,J=4.5Hz,1H),2.11–2.05(m,1H),2.00(d,J=18.9Hz,1H),1.84–1.79(m,1H),1.53–1.48(m,1H),1.03(s,3H),0.93(s,3H).13C NMR(150MHz,CDCl3)δ219.53,152.50,141.13,125.79,112.39,59.01,49.63,46.84,43.04,42.53,27.04,25.82,19.81,19.26.
Example 5
Figure BDA0003551204690000072
Dissolving 4-chlorophenylhydrazine hydrochloride (1.0mmol), 4-dimethylaminopyridine (0.1mmol) and triethylamine (1.1mmol) in anhydrous dichloromethane, cooling to 0 ℃, adding L-10-camphorsulfonyl chloride (1.1mol) in batches, raising the temperature to 25 ℃, reacting for 9h, monitoring the reaction completion of raw materials by TLC, washing an organic layer with water for 3 times (8mL x 3), washing with saturated saline solution for 3 times (8mL x 3), drying, performing suction filtration, concentrating to remove dichloromethane, and performing column chromatography on a crude product (CH)2Cl2MeOH ═ 20:1) gave the title compound I-5 as a pale yellow solid, m.p.131-133 ℃, yield 33%.1H NMR(600MHz,CDCl3)δ7.21(d,J=8.8Hz,2H),6.98(d,J=8.8Hz,2H),6.40(s,1H),3.70(d,J=15.5Hz,1H),2.88(d,J=15.5Hz,1H),2.46–2.42(m,1H),2.34–2.29(m,1H),2.18(t,J=4.4Hz,1H),2.10–2.04(m,1H),1.98(d,J=18.8Hz,1H),1.87–1.83(m,1H),1.67(s,1H),1.51–1.47(m,1H),1.03(s,3H),0.92(s,3H).13C NMR(150MHz,CDCl3)δ218.66,145.67,129.01,125.95,115.17,58.99,49.37,46.90,43.02,42.60,27.05,26.03,19.85,19.33.
Example 6
Figure BDA0003551204690000081
Dissolving 3-chlorophenylhydrazine hydrochloride (1.0mmol), 4-dimethylaminopyridine (0.1mmol) and triethylamine (1.1mmol) in anhydrous dichloromethane, cooling to 0 ℃, adding L-10-camphorsulfonyl chloride (1.1mol) in batches, raising the temperature to 25 ℃, reacting for 8h, monitoring by TLC that the raw materials are completely reacted, washing the organic layer with water for 3 times (8ml x 3), and using saturated salt solutionWashing 3 times (8mL of 3), drying, filtering, concentrating to remove dichloromethane, and purifying the crude product by column Chromatography (CH)2Cl2MeOH ═ 20:1) gave the title compound I-6, a pale yellow solid, m.p.136.5-139.5 ℃ in 79.2% yield.1H NMR(600MHz,CDCl3)δ7.16(t,J=8.0Hz,1H),7.06(t,J=2.1Hz,1H),6.91–6.87(m,2H),6.43(s,1H),3.69(d,J=15.5Hz,1H),2.89(d,J=15.5Hz,1H),2.46–2.41(m,1H),2.34–2.28(m,1H),2.18(t,J=4.5Hz,1H),2.10–2.04(m,1H),1.98(d,J=18.8Hz,1H),1.87–1.82(m,1H),1.51–1.47(m,1H),1.02(s,3H),0.92(s,3H).13C NMR(150MHz,CDCl3)δ218.74,148.29,134.95,130.16,121.16,113.91,111.96,59.00,49.39,46.89,43.01,42.60,27.05,26.01,19.81,19.30.
Example 7
Figure BDA0003551204690000082
Dissolving 4-fluorophenylhydrazine hydrochloride (1.0mmol), 4-dimethylaminopyridine (0.1mmol) and triethylamine (1.1mmol) in anhydrous dichloromethane, cooling to 0 ℃, adding L-10-camphorsulfonyl chloride (1.1mol) in batches, raising the temperature to 25 ℃, reacting for 10h, monitoring the reaction completion of raw materials by TLC, washing an organic layer with water for 3 times (8mL x 3), washing with saturated saline water for 3 times (8mL x 3), drying, performing suction filtration, concentrating to remove dichloromethane, and performing column Chromatography (CH) on a crude product2Cl2MeOH ═ 20:1) to give the title compound I-7, a pale yellow solid, m.p.91-93 ℃ yield 51%.1HNMR(600MHz,CDCl3)δ7.07–6.83(m,4H),6.43(s,1H),3.70(d,J=15.4Hz,1H),2.87(d,J=15.5Hz,1H),2.46–2.41(m,1H),2.33–2.28(m,1H),2.18(t,J=4.5Hz,1H),2.10–2.04(m,1H),1.97(d,J=18.8Hz,1H),1.88–1.84(m,1H),1.51–1.47(m,1H),1.02(s,3H),0.92(s,3H).13C NMR(150MHz,CDCl3)δ218.58,158.03(d,J=237.5Hz),143.13(d,J=2.3Hz),115.66(d,J=22.6Hz),115.41(d,J=7.8Hz),115.41(d,J=7.8Hz),59.04,49.37,46.85,43.05,42.64,27.08,26.13,19.85,19.35.
Example 8
Figure BDA0003551204690000091
Dissolving 2,4, 6-trichlorophenylhydrazine hydrochloride (1.0mmol), 4-dimethylaminopyridine (0.1mmol) and triethylamine (1.1mmol) in anhydrous dichloromethane, cooling to 0 ℃, adding L-10-camphorsulfonyl chloride (1.1mol) in batches, raising the temperature to 25 ℃, reacting for 9.5h, monitoring the completion of the reaction of the raw materials by TLC, washing an organic layer with water for 3 times (8mL x 3), washing with saturated saline for 3 times (8mL 3), drying, performing suction filtration, concentrating to remove dichloromethane, performing column chromatography on a crude product (CH)2Cl2MeOH, 20:1) gave the title compound, I-8, as a white solid, m.p. 128.9-129.5 ℃ with a yield of 90.5%.1H NMR(600MHz,CDCl3)δ7.30(s,2H),7.19(s,1H),6.67(s,1H),3.62(d,J=15.3Hz,1H),2.83(d,J=15.4Hz,1H),2.45–2.33(m,2H),2.16(t,J=4.5Hz,1H),2.08–2.03(m,1H),1.98(d,J=18.7Hz,1H),1.82–1.77(m,1H),1.50–1.46(m,1H),1.01(s,3H),0.86(s,3H).13C NMR(150MHz,CDCl3)δ217.13,138.93,128.99,128.73,127.55,58.58,48.87,48.03,42.73,42.55,26.97,25.00,19.66,19.38.
Example 9
Figure BDA0003551204690000101
Dissolving 4-trifluoromethoxy phenylhydrazine hydrochloride (1.0mmol), 4-dimethylamino pyridine (0.1mmol) and triethylamine (1.1mmol) in anhydrous dichloromethane, cooling to 0 ℃, adding L-10-camphorsulfonyl chloride (1.1mol) in batches, raising the temperature to 25 ℃, reacting for 6.5h, monitoring the completion of the reaction of the raw materials by TLC, washing an organic layer with water for 3 times (8mL x 3), washing with saturated saline water for 3 times (8mL x 3), drying, performing suction filtration, concentrating to remove dichloromethane, and performing column chromatography on a crude product (CH)2Cl2MeOH ═ 20:1) to give the title compound I-9, a beige solid, in 30% yield at m.p.95-97 ℃.1H NMR(600MHz,CDCl3)δ7.11(d,J=8.7Hz,2H),7.04(d,J=9.0Hz,2H),6.45(s,1H),3.71(d,J=15.5Hz,1H),2.88(d,J=15.5Hz,1H),2.46–2.42(m,1H),2.33–2.29(m,1H),2.18(t,J=4.4Hz,1H),2.10–2.06(m,1H),1.98(d,J=18.8Hz,1H),1.88–1.83(m,1H),1.51–1.47(m,1H),1.02(s,3H),0.92(s,3H).13C NMR(150MHz,CDCl3)δ218.91,145.73,143.21(d,J=1.5Hz),122.22,118.8(q,J=254.6Hz),114.57,59.01,49.45,46.68,43.03,42.57,27.05,26.04,19.81,19.29.
Example 10
Figure BDA0003551204690000102
Dissolving 4-bromophenylhydrazine hydrochloride (1.0mmol), 4-dimethylaminopyridine (0.1mmol) and triethylamine (1.1mmol) in anhydrous dichloromethane, cooling to 0 ℃, adding L-10-camphorsulfonyl chloride (1.1mol) in batches, raising the temperature to 25 ℃, reacting for 7.5h, monitoring the completion of the reaction of the raw materials by TLC, washing an organic layer with water for 3 times (8mL x 3), washing with saturated saline solution for 3 times (8mL x 3), drying, performing suction filtration, concentrating to remove dichloromethane, and performing column chromatography on a crude product (CH)2Cl2MeOH ═ 20:1) gave the title compound I-10 as a beige solid, m.p.109-111.5 ℃ in 20.5% yield.1H NMR(600MHz,CDCl3)δ7.34(d,J=8.8Hz,2H),6.93(d,J=8.8Hz,2H),6.40(s,1H),3.70(d,J=15.5Hz,1H),2.88(d,J=15.5Hz,1H),2.46–2.42(m,1H),2.34–2.29(m,1H),2.18(t,J=4.5Hz,1H),2.10–2.05(m,1H),1.98(d,J=18.8Hz,1H),1.87–1.82(m,1H),1.51–1.47(m,1H),1.03(s,3H),0.92(s,3H).13C NMR(150MHz,CDCl3)δ218.65,146.20,131.91,115.55,113.20,58.99,49.37,46.79,43.01,42.61,27.05,26.00,19.82,19.33.
Example 11
Figure BDA0003551204690000111
Dissolving 2-chloro-4-fluorophenylhydrazine hydrochloride (1.0mmol), 4-dimethylaminopyridine (0.1mmol) and triethylamine (1.1mmol) in anhydrous dichloromethane, cooling to 0 ℃, adding L-10-camphorsulfonyl chloride (1.1mol) in batches, raising the temperature to 25 ℃ for reaction for 5.5h, monitoring the completion of the reaction of the raw materials by TLC, washing the organic layer with water for 3 times (8mL x 3), washing the organic layer with saturated saline water for 3 times (8mL x 3), drying, suction filtering, concentrating to remove dichloromethane, and performing column chromatography on the crude product (CH)2Cl2MeOH 20:1) to obtain the target compound I-11, beige solidM.p.133.1-135 deg.C, yield 79%.1H NMR(600MHz,CDCl3)δ7.35(dd,J=9.1,5.3Hz,1H),7.11(s,1H),7.03(dd,J=8.1,2.8Hz,1H),6.97–6.94(m,1H),6.45(s,1H),3.79(d,J=15.5Hz,1H),2.89(d,J=15.5Hz,1H),2.49–2.45(m,1H),2.34–2.29(m,1H),2.19(t,J=4.5Hz,1H),2.10–2.05(m,1H),1.99(d,J=18.8Hz,1H),1.88–1.84(m,1H),1.52–1.48(m,1H),1.04(s,3H),0.94(s,3H).13C NMR(150MHz,CDCl3)δ219.13,156.76(d,J=240.5Hz),139.70,118.58(d,J=10.5Hz),116.16(d,J=3.9Hz),116.05(d,J=13.8Hz),114.76(d,J=21.9Hz),59.02,49.5,46.41,43.05,42.59,27.08,26.06,19.80,19.29.
Example 12
Figure BDA0003551204690000121
Dissolving 3, 5-bis (trifluoromethyl) phenylhydrazine hydrochloride (1.0mmol), 4-dimethylamino pyridine (0.1mmol) and triethylamine (1.1mmol) in anhydrous dichloromethane, cooling to 0 deg.C, adding L-10-camphorsulfonyl chloride (1.1mol) in batches, heating to 25 deg.C, reacting for 6.5h, monitoring by TLC that the raw materials are completely reacted, washing the organic layer with water for 3 times (8mL x 3), washing with saturated saline solution for 3 times (8mL x 3), drying, suction filtering, concentrating to remove dichloromethane, and performing column chromatography on the crude product (CH)2Cl2MeOH 20:1) gave the title compound I-12 as a white solid, m.p.136.5-137.5 ℃, yield 29.0%.1H NMR(600MHz,CDCl3)δ7.45(s,2H),7.38(s,1H),7.18(s,1H),6.48(s,1H),3.71(d,J=15.6Hz,1H),2.92(d,J=15.6Hz,1H),2.49–2.45(m,1H),2.37–2.31(m,1H),2.22(t,J=4.5Hz,1H),2.13–2.07(m,1H),2.01(d,J=18.9Hz,1H),1.86–1.81(m,1H),1.54–1.50(m,1H),1.04(s,3H),0.95(s,3H).13C NMR(150MHz,CDCl3)δ219.62,148.32,132.4(q,J=33.0Hz),123.3(q,J=271.1Hz),120.53,114.17(q,J=3.8Hz),113.24(d,J=3.0Hz),59.05,49.65,46.70,43.04,42.54,27.01,25.96,19.75,19.20.
Example 13
Figure BDA0003551204690000122
Dissolving 2, 4-dichlorohydrazinium hydrochloride (1.0mmol), 4-dimethylaminopyridine (0.1mmol) and triethylamine (1.1mmol) in anhydrous dichloromethane, cooling to 0 ℃, adding L-10-camphorsulfonyl chloride (1.1mol) in batches, raising the temperature to 25 ℃, reacting for 6h, monitoring the completion of the reaction of the raw materials by TLC, washing an organic layer with water for 3 times (8mL x 3), washing with saturated saline water for 3 times (8mL x 3), drying, performing suction filtration, concentrating to remove dichloromethane, and performing column chromatography on a crude product (CH)2Cl2MeOH ═ 20:1) gave the title compound I-13 as a beige solid, m.p.125-126.5 ℃ in 76.1% yield.1H NMR(600MHz,CDCl3)δ7.32(d,J=8.8Hz,1H),7.25(s,2H),7.18(dd,J=8.8,2.2Hz,1H),6.44(s,1H),3.77(d,J=15.5Hz,1H),2.89(d,J=15.5Hz,1H),2.49–2.45(m,1H),2.35–2.30(m,1H),2.19(t,J=4.4Hz,1H),2.11–2.01(m,1H),1.99(d,J=18.9Hz,1H),1.87–1.82(m,1H),1.52–1.48(m,1H),1.04(s,3H),0.94(s,3H).13C NMR(150MHz,CDCl3)δ219.14,141.96,128.61,127.94,125.42,118.78,115.94,77.00,59.03,49.52,46.54,43.05,42.62,27.09,26.04,19.81,19.29.
Example 14
Figure BDA0003551204690000131
Dissolving 4-iodophenylhydrazine hydrochloride (1.0mmol), 4-dimethylaminopyridine (0.1mmol) and triethylamine (1.1mmol) in anhydrous dichloromethane, cooling to 0 ℃, adding L-10-camphorsulfonyl chloride (1.1mol) in batches, raising the temperature to 25 ℃, reacting for 5 hours, monitoring the reaction completion of the raw materials by TLC, washing an organic layer with water for 3 times (8mL x 3), washing with saturated saline for 3 times (8mL x 3), drying, performing suction filtration, concentrating to remove dichloromethane, and performing column chromatography on a crude product (CH)2Cl2MeOH 20:1) gave the title compound I-14 as a pale yellow solid, m.p. 101-103 ℃.1H NMR(600MHz,CDCl3)δ7.52(d,J=8.6Hz,2H),6.82(d,J=8.7Hz,2H),6.38(s,1H),3.69(d,J=15.4Hz,1H),2.87(d,J=15.4Hz,1H),2.46–2.42(m,1H),2.34–2.29(m,1H),2.18(t,J=4.4Hz,1H),2.09–2.07(m,1H),1.98(d,J=18.8Hz,1H),1.86–1.82(m,1H),1.51–1.47m,1H),1.03(s,3H),0.92(s,3H).13C NMR(150MHz,CDCl3)δ218.73,146.84,137.83,115.98,83.04,59.02,49.41,46.86,43.04,42.62,27.08,26.05,19.85,19.33.
Example 15
Figure BDA0003551204690000141
Dissolving 2, 4-difluorophenylhydrazine hydrochloride (1.0mmol), 4-dimethylaminopyridine (0.1mmol) and triethylamine (1.1mmol) in anhydrous dichloromethane, cooling to 0 ℃, adding L-10-camphorsulfonyl chloride (1.1mol) in portions, raising the temperature to 25 ℃ for reaction for 5.5h, monitoring the completion of the reaction of the raw materials by TLC, washing the organic layer with water for 3 times (8 mL. x.3), washing with saturated saline for 3 times (8 mL. x.3), drying, suction filtering, concentrating to remove dichloromethane, and performing column chromatography on the crude product (CH)2Cl2MeOH ═ 20:1) gave the title compound I-15 as a yellow solid, m.p.103-105 ℃ in 65% yield.1H NMR(600MHz,CDCl3)δ7.36–7.32(m,1H),6.84–6.78(m,2H),6.45(s,1H),3.76(d,J=15.5Hz,1H),2.89(d,J=15.5Hz,1H),2.48–2.44(m,1H),2.33–2.27(m,1H),2.19(t,J=4.5Hz,1H),2.10–2.06(m,1H),1.98(d,J=18.8Hz,1H),1.90–1.85(m,1H),1.52–1.48(m,1H),1.03(s,3H),0.94(s,3H).13C NMR(150MHz,CDCl3)δ218.89,156.86(d,J=239.4,10.7Hz),150.31(d,J=241.5,12.0Hz),131.61(dd,J=10.5,3.1Hz),116.94(dd,J=8.9,3.3Hz),111.22(dd,J=21.9,3.6Hz),103.54(d,J=22.1Hz),103.36(d,J=22.2Hz),103.28,59.06,49.45,46.58,43.03,42.64,27.07,26.18,19.84,19.31.
Example 16
Figure BDA0003551204690000142
Dissolving 2-pyridylhydrazine hydrochloride (1.0mmol), 4-dimethylaminopyridine (0.1mmol) and triethylamine (1.1mmol) in anhydrous dichloromethane, cooling to 0 ℃, adding L-10-camphorsulfonyl chloride (1.1mol) in batches, raising the temperature to 25 ℃, reacting for 6h, monitoring the completion of the reaction of the raw materials by TLC, washing an organic layer with water for 3 times (8mL x 3), washing with saturated saline solution for 3 times (8mL x 3), drying, filtering, concentrating, and performing concentrationDichloromethane is removed and the crude product is Chromatographed (CH)2Cl2MeOH ═ 20:1) gave the title compound I-16, a yellow solid, m.p.163-165 ℃ in 69% yield.1H NMR(600MHz,CDCl3)δ8.11(d,J=5.9Hz,1H),7.63–7.56(m,1H),7.49(s,1H),7.10(d,J=8.4Hz,1H),6.81(dd,J=6.8,4.8Hz,1H),3.80(d,J=15.5Hz,1H),2.91(d,J=15.5Hz,1H),2.43–2.39(m,1H),2.26–2.22(m,1H),2.14(t,J=4.5Hz,1H),2.07–2.01(m,1H),1.97–1.93(m,2H),1.49–1.44(m,1H),1.01(s,3H),0.86(s,3H).13C NMR(150MHz,CDCl3)δ217.72,158.61,146.90,138.57,116.52,108.38,59.17,49.21,47.08,42.98,42.74,27.05,26.45,19.74,19.35.
Example 17
Figure BDA0003551204690000151
Dissolving 3-fluorophenylhydrazine hydrochloride (1.0mmol), 4-dimethylaminopyridine (0.1mmol) and triethylamine (1.1mmol) in anhydrous dichloromethane, cooling to 0 ℃, adding L-10-camphorsulfonyl chloride (1.1mol) in batches, raising the temperature to 25 ℃ for reacting for 6.5h, monitoring the complete reaction of the raw materials by TLC, washing an organic layer with water for 3 times (8mL x 3), washing an organic layer with saturated saline solution for 3 times (8mL x 3), drying, performing suction filtration, concentrating to remove dichloromethane, and performing column chromatography on a crude product (CH)2Cl2MeOH ═ 20:1) gave the title compound I-17 as a yellow solid, m.p.139-139.5 ℃ in 59% yield.1H NMR(600MHz,CDCl3)δ7.17(td,J=8.1,6.4Hz,1H),6.84–6.73(m,2H),6.59(td,J=8.4,2.3Hz,1H),6.49(s,1H),3.69(d,J=15.4Hz,1H),2.89(d,J=15.4Hz,1H),2.46–2.41(m,1H),2.33–2.28(m,1H),2.17(t,J=4.5Hz,1H),2.09–2.03(m,1H),1.97(d,J=18.8Hz,1H),1.86–1.81(m,1H),1.50–1.46(m,1H),1.02(s,3H),0.91(s,3H).13C NMR(150MHz,CDCl3)δ218.66,163.71(d,J=243.0Hz),148.96(d,J=10.2Hz),130.35(d,J=9.6Hz),109.27(d,J=2.6Hz),107.76(d,J=21.4Hz),101.25(d,J=26.0Hz),77.00,59.00,49.38,46.91,43.01,42.61,27.05,26.02,19.81,19.31.
Example 18
Figure BDA0003551204690000161
Dissolving 2-fluorophenylhydrazine hydrochloride (1.0mmol), 4-dimethylaminopyridine (0.1mmol) and triethylamine (1.1mmol) in anhydrous dichloromethane, cooling to 0 ℃, adding L-10-camphorsulfonyl chloride (1.1mol) in batches, raising the temperature to 25 ℃, reacting for 6.5h, monitoring the reaction completion of the raw materials by TLC, washing an organic layer with water for 3 times (8mL x 3), washing with saturated saline water for 3 times (8mL x 3), drying, performing suction filtration, concentrating to remove dichloromethane, and performing column chromatography on a crude product (CH)2Cl2MeOH ═ 20:1) gave the title compound I-18 as a yellow solid, m.p.137.9-138.5 ℃ in 60% yield.1H NMR(600MHz,CDCl3)δ7.37(td,J=8.4,1.6Hz,1H),7.08(t,J=7.8Hz,1H),7.02–6.99(m,1H),6.86–6.83(m,2H),6.44(s,1H),3.76(d,J=15.5Hz,1H),2.90(d,J=15.5Hz,1H),2.48–2.43(m,1H),2.34–2.29(m,1H),2.18(t,J=4.5Hz,1H),2.10–2.05(m,1H),1.98(d,J=18.8Hz,1H),1.90–1.85(m,1H),1.51–1.47(m,1H),1.03(s,3H),0.94(s,3H).13C NMR(150MHz,CDCl3)δ218.59,150.83(d,J=238.4Hz),135.15(d,J=10.0Hz),124.67(d,J=3.5Hz),121.03(d,J=7.0Hz),116.02(d,J=2.1Hz),114.80(d,J=17.9Hz),59.03,49.36,46.70,42.99,42.64,27.06,26.11,19.83,19.33.
Example 19
The method of the camphor sulfonyl hydrazide compound I-19 is schematically shown in figure 2, and the specific preparation process comprises the following steps:
1-naphthylhydrazine hydrochloride (1.0mmol), 4-dimethylaminopyridine (0.1mmol) and triethylamine (1.1mmol) are dissolved in anhydrous dichloromethane, the temperature is reduced to 0 ℃, L-10-camphorsulfonyl chloride (1.1mol) is added in batches, and the mixture is heated to 25 ℃ for reaction for 6 hours. The TLC monitored the starting material reaction was complete, the organic layer was washed 3 times with water (8mL x 3), 3 times with saturated brine (8mL x 3), dried, filtered with suction, concentrated to remove dichloromethane, and the crude product was chromatographed (CH2Cl2: MeOH ═ 20:1) to give the title compound I-19. brown solid, m.p.133.8-135.1 ℃ yield 65%.
1H NMR(600MHz,CDCl3)δ7.91(d,J=8.8Hz,1H),7.84–7.82(m,1H),7.50–7.37(m,5H),6.33(s,1H),3.83(d,J=15.5Hz,1H),2.93(d,J=15.5Hz,1H),2.51–2.38(m,2H),2.19(t,J=4.4Hz,1H),2.10–1.99(m,1H),2.01(d,J=18.8Hz,1H),1.88–1.83(m,1H),1.52–1.48(m,1H),1.03(s,3H),0.93(s,3H).13C NMR(150MHz,CDCl3)δ218.74,141.75,134.06,128.60,126.24,125.86,125.40,122.66,121.19,119.81,108.61,58.97,49.34,46.98,43.03,42.57,27.05,25.75,19.78,19.33.
Example 20
Dissolving 2-chloro-4-fluorophenylhydrazine hydrochloride (1.0mmol), 4-dimethylaminopyridine (0.1mmol) and triethylamine (1.1mmol) in the solution, cooling to 0 ℃, adding L-10-camphorsulfonyl chloride (1.1mol) in batches, raising the temperature to 25 ℃ and reacting for 5.5 h. The reaction is post-treated to obtain the compound I-11, and the yield is counted.
Figure BDA0003551204690000171
The yield factors of three solvents for the hydrazidation reaction are discussed, wherein dichloromethane is used as the solvent, and the reaction yield is highest (79%); using trichloromethane as solvent, the yield is inferior; tetrahydrofuran is used as solvent, and the yield is lowest (50%). Therefore, methylene chloride is most preferably used as a solvent for the hydrazide reaction.
Example 21
Bactericidal activity (in vitro) test
The plant fungi used in the experiment are strains stored at 4 ℃ in a laboratory, such as botrytis cinerea, fusarium graminearum, potato late blight, phytophthora capsici, hickory nut stem rot, sclerotinia sclerotiorum, apple ring rot and rice sheath blight. The adopted culture medium is a potato agar glucose culture medium (PDA for short). The PDA culture medium formula comprises 200g of potato (peeled), 20g of glucose, 15g of agar and 1000mL of distilled water, and the preparation method comprises the following steps: cleaning and peeling potatoes, weighing 200g of potatoes, cutting the potatoes into small pieces, adding water, boiling the potatoes thoroughly (boiling for 20-30 minutes and being capable of being punctured by a glass rod), filtering the potatoes in a beaker by eight layers of gauze, adding 15-20 g of agar according to experimental requirements, adding 20g of glucose, stirring the mixture evenly, slightly cooling the mixture after the mixture is fully dissolved, supplementing water to 1000mL, sterilizing the mixture for 15 minutes at 121 ℃ after split charging, and cooling the mixture for later use.
The experimental method comprises the following steps: a growth rate method is used.
(1) Firstly, 8 plant fungi are cultured on a PDA flat plate at 25 ℃ for about 3-6 days for later use;
(2) heating PDA culture medium to melt, cooling to 45-50 deg.C, adding 250 μ L of 10g/L compound to be tested to obtain culture medium containing 50mg/L medicinal liquid, and respectively cooling in culture dish to obtain a positive control of diflucan hydroxylamine (pydiflumetofen);
(3) using a puncher to punch a circular fungus cake (with the diameter of 0.50cm) at the edge of each strain hypha (the growth condition is consistent as much as possible) cultured for 6d in a sterile operation, then using an inoculating needle to pick the disc to the center of a drug-containing flat plate, and then placing the culture dish in an incubator (28 ℃) for culture;
(4) observing and measuring the growth condition of hyphae at different time after treatment, measuring the diameter by adopting a cross method, processing data and calculating the inhibition rate;
(5) inhibition (%) × (control hypha diameter-treated hypha diameter)/(control hypha diameter-0.5) × 100;
(6) each treatment was repeated 3 times.
TABLE 1 test results of inhibitory Activity of Camphorsulfonyl hydrazides against eight agricultural pathogenic fungi
Figure BDA0003551204690000181
Figure BDA0003551204690000191
Note a three replicates per treatment were set up in the experiment and the data in the table are the average of the three replicates.
EC of part of the Compounds of Table 250Value of
Figure BDA0003551204690000192
The results of the bactericidal activity measurements of the experimental groups I-1 to I-19 and the control agent fluxapyroxad are shown in tables 1 and 2. As can be seen from the results in tables 1 and 2, at a concentration of 50mg/L, the compounds I-1 to I-19 showed bactericidal activities of different degrees on 8 plant fungi, and part of the compounds had better inhibitory activities on Phytophthora capsici, Gibberella zeae and Sclerotinia hickory; wherein the inhibition rate of the compound I-6, I-8 and I-13 to phytophthora capsici in the concentration of 50mg/L reaches 98 percent;
in addition, the inhibition rate of the compounds on the hickory nut dry rot is more than 90 percent, and is equivalent to that of positive control fluxapyroxad hydroxylamine; for wheat scab, the inhibition rate of individual compounds such as I-1, I-6, I-11, I-13, I-15 and I-17 on the wheat scab reaches 90%, which is equivalent to that of positive control fluxapyroxad.
As the target compound has better inhibitory activity to several plant pathogenic bacteria, the EC of the compound with higher inhibition rate of the general sieve is tested50The value is obtained. EC of a part of the Compounds50As shown in Table 2, it can be seen that the compounds I-1, I-11 and I-13 have EC against Gibberella cerealis50All values are less than 1.0mg/L, EC of Compound I-1150The value was 0.407mg/L, close to the positive control fluxapyroxad hydroxylamine (0.296 mg/L). In addition, part of the compounds have EC against Phytophthora capsici50Values were between 0.9-1.5mg/L, close to the positive control. The series of compounds have good inhibitory activity on several fungi and have the potential of developing antifungal agents.
The camphor compound containing the sulfonyl hydrazide group has obvious structural difference and distinct chemical structural characteristics, and has better effect on preventing and treating wheat scab, phytophthora capsici leonian and hickory nut dry rot. Can be used for preventing and treating fungal diseases of agricultural or forestry plants. The preparation method of the compound is simple and convenient, the yield is high, and the product property is stable.
It should be noted that the above-mentioned embodiments are only for illustrating the technical solutions of the present invention and not for limiting, and although the present invention has been described in detail with reference to the preferred embodiments, it should be understood by those skilled in the art that modifications or equivalent substitutions may be made on the technical solutions of the present invention without departing from the spirit and scope of the technical solutions of the present invention, which should be covered by the claims of the present invention.

Claims (10)

1. The camphor sulfonyl hydrazide compound is characterized in that: the structural formula of the camphor sulfonyl hydrazine compound is shown as follows:
Figure FDA0003551204680000011
2. the process for producing a camphorsulfonyl hydrazide compound as claimed in claim 1, wherein: comprises the steps of (a) preparing a substrate,
reacting the L-10-camphorsulfonic acid with thionyl chloride to synthesize an L-10-camphorsulfonyl chloride intermediate;
reacting the L-10-camphorsulfonyl chloride intermediate with substituted phenylhydrazine hydrochloride, triethylamine and 4-dimethylamino pyridine to synthesize camphorsulfonyl hydrazide compounds I-1 to I-18;
the L-10-camphorsulfonyl chloride intermediate reacts with 1-naphthylhydrazine hydrochloride, triethylamine and 4-dimethylamino pyridine to synthesize the camphorsulfonyl hydrazide compound I-19.
3. The process for producing a camphorsulfonyl hydrazide compound as claimed in claim 2, wherein: an intermediate of L-10-camphorsulfonyl chloride, a process for its preparation, comprising,
adding 3.0mmol of L-10-camphorsulfonic acid and 3.3mmol of thionyl chloride into a single-mouth bottle for dissolving, heating to the reflux temperature for reaction for 5 hours, cooling, concentrating and removing most of solvent and HCl to obtain white solid L-10-camphorsulfonyl chloride.
4. The process for producing a camphorsulfonyl hydrazide compound as claimed in claim 2, wherein: the feeding molar ratio of the intermediate L-10-camphorsulfonyl chloride to the substituted phenylhydrazine hydrochloride is 1.1: 1.
5. The process for producing a camphorsulfonyl hydrazide compound as claimed in claim 2, wherein: the feeding molar ratio of the substituted phenylhydrazine hydrochloride to the triethylamine is 1: 1.1.
6. The process for producing a camphorsulfonyl hydrazide compound as claimed in claim 2, wherein: the molar ratio of the L-10-camphorsulfonyl chloride intermediate to the 4-dimethylaminopyridine was 1.1: 0.1.
7. The process for the preparation of camphorsulfonyl hydrazines as claimed in claim 2 wherein: synthesizing camphor sulfonyl hydrazide compounds I-1-I-18, wherein the synthesis reaction temperature is 25 ℃, and the reaction time is 5-10 h; the camphor sulfonyl hydrazide compound I-19 is synthesized by reaction, the reaction temperature is 25 ℃, and the reaction time is 5-10 h.
8. The process for the preparation of camphorsulfonyl hydrazines as claimed in claim 2 wherein: the feeding molar ratio of the intermediate L-10-camphorsulfonyl chloride to the 1-naphthylhydrazine hydrochloride is 1.1: 1.
9. The use of camphorsulfonyl hydrazide compounds as claimed in claim 1 for controlling plant fungi in agriculture or forestry.
10. The use of claim 9, wherein: the plant fungi include Gibberella zeae, Phytophthora capsici and Carya cathayensis.
CN202210264700.6A 2022-03-17 2022-03-17 Preparation method of camphorsulfonyl hydrazides compound, camphorsulfonyl hydrazides compound product and application of camphorsulfonyl hydrazides compound product Active CN114621121B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210264700.6A CN114621121B (en) 2022-03-17 2022-03-17 Preparation method of camphorsulfonyl hydrazides compound, camphorsulfonyl hydrazides compound product and application of camphorsulfonyl hydrazides compound product

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210264700.6A CN114621121B (en) 2022-03-17 2022-03-17 Preparation method of camphorsulfonyl hydrazides compound, camphorsulfonyl hydrazides compound product and application of camphorsulfonyl hydrazides compound product

Publications (2)

Publication Number Publication Date
CN114621121A true CN114621121A (en) 2022-06-14
CN114621121B CN114621121B (en) 2024-03-29

Family

ID=81901123

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210264700.6A Active CN114621121B (en) 2022-03-17 2022-03-17 Preparation method of camphorsulfonyl hydrazides compound, camphorsulfonyl hydrazides compound product and application of camphorsulfonyl hydrazides compound product

Country Status (1)

Country Link
CN (1) CN114621121B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115197134A (en) * 2022-07-14 2022-10-18 南京林业大学 Preparation method and application of camphorsulfonate compounds
CN116813572A (en) * 2023-05-31 2023-09-29 南京林业大学 Preparation method of camphoric acid formylhydrazine compound, product and application thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH111469A (en) * 1997-04-14 1999-01-06 Sumitomo Chem Co Ltd Camphor disulfone derivative, its intermediate, its production and use
JP2002179659A (en) * 2000-08-23 2002-06-26 Sumika Fine Chemicals Co Ltd Method for producing camphorsultam
CN109232468A (en) * 2018-11-06 2019-01-18 南京林业大学 A kind of camphorsulfonic acid thiosemicarbazones thiazole compound, preparation method and its application
CN110003133A (en) * 2019-03-05 2019-07-12 上海工程技术大学 A kind of chiral camphor sulfohydrazide bifunctional catalyst and the preparation method and application thereof
WO2020169682A1 (en) * 2019-02-19 2020-08-27 Yncrea Hauts De France Hydrazide derivatives and their specific use as antibacterial agents by controlling acinetobacter baumannii bacterium
CN111848463A (en) * 2020-07-08 2020-10-30 南京林业大学 Camphor sulfanilamide oxime ether compound and preparation method and application thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH111469A (en) * 1997-04-14 1999-01-06 Sumitomo Chem Co Ltd Camphor disulfone derivative, its intermediate, its production and use
JP2002179659A (en) * 2000-08-23 2002-06-26 Sumika Fine Chemicals Co Ltd Method for producing camphorsultam
CN109232468A (en) * 2018-11-06 2019-01-18 南京林业大学 A kind of camphorsulfonic acid thiosemicarbazones thiazole compound, preparation method and its application
WO2020169682A1 (en) * 2019-02-19 2020-08-27 Yncrea Hauts De France Hydrazide derivatives and their specific use as antibacterial agents by controlling acinetobacter baumannii bacterium
CN110003133A (en) * 2019-03-05 2019-07-12 上海工程技术大学 A kind of chiral camphor sulfohydrazide bifunctional catalyst and the preparation method and application thereof
CN111848463A (en) * 2020-07-08 2020-10-30 南京林业大学 Camphor sulfanilamide oxime ether compound and preparation method and application thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
YANG, ZIHUI: "Novel Camphor Sulfonohydrazide and Sulfonamide Derivatives as Potential Succinate Dehydrogenase Inhibitors against Phytopathogenic Fungi/Oomycetes", JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, vol. 71, no. 1, 23 December 2022 (2022-12-23), pages 174 - 185 *
马献力 等: "樟脑酸基双酰肼化合物的合成及其抑菌活性", 精细化工, vol. 32, no. 12, 31 December 2015 (2015-12-31), pages 1426 - 1430 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115197134A (en) * 2022-07-14 2022-10-18 南京林业大学 Preparation method and application of camphorsulfonate compounds
CN115197134B (en) * 2022-07-14 2024-07-30 南京林业大学 Preparation method and application of camphorsulfonate compounds
CN116813572A (en) * 2023-05-31 2023-09-29 南京林业大学 Preparation method of camphoric acid formylhydrazine compound, product and application thereof
CN116813572B (en) * 2023-05-31 2024-03-12 南京林业大学 Preparation method of camphoric acid formylhydrazine compound, product and application thereof

Also Published As

Publication number Publication date
CN114621121B (en) 2024-03-29

Similar Documents

Publication Publication Date Title
CN114621121A (en) Preparation method of camphor sulfonyl hydrazine compound, product and application thereof
CN114436911B (en) Preparation method and application of camphorsulfonyl benzylamine compound
CN107711855B (en) Application of camelinine A derivative in preparation of medicines for preventing and treating or resisting plant diseases
NO141340B (en) ANILIDES FOR USE AS MICROBICIDES
CN102612938A (en) Chinese yam planting method for preventing reduction of continuous cropping yield
CN115197134B (en) Preparation method and application of camphorsulfonate compounds
CN111196785B (en) Triazole derivative and preparation method and application thereof
CN104926725B (en) Naphthalimide arylurea compound and use thereof
CN114805219B (en) Fluorine-containing pyrimidine diether compound and application thereof
CN111377870A (en) 2, 4-dioxoimidazolines cyclohexane sulfonamide compounds, process for their preparation and their use as fungicides or bactericides
CN113773288B (en) Heterocyclic dehydroabietyl formamide compound and preparation method and application thereof
CN116813572B (en) Preparation method of camphoric acid formylhydrazine compound, product and application thereof
CN111937886A (en) Preparation of 8-hydroxyquinoline complex and application thereof in preventing and treating plant diseases
CN111393348B (en) Nitrogen-substituted phenylpyrrole compound and application thereof in plant sterilization
JPS63258478A (en) Macrocyclic compound, its production and control of plant disease using said compound
CN112136824B (en) Application of quassin compounds in preventing and treating plant fungal diseases
CN111499554B (en) Phenyl pyrrole compound and application of bactericidal activity thereof
CN113880765A (en) Diphenyl ether group-containing 4- (1H-pyrazole-1-yl) biphenyl formamide compound and application thereof
CN114680114B (en) Application of melatonin derivative in preventing and treating plant fungal diseases
CN117402076A (en) Preparation method of norbornenyl acid formylhydrazine compound, product and application thereof
CN116789574B (en) Preparation method and application of camphorsulfonamide compound containing diphenyl ether group
CN116082313A (en) Compound for preventing and treating plant fungal diseases and preparation method thereof
CN115028635B (en) Skeleton transition type berberine analogue and application thereof in preventing and treating agricultural diseases
CN102503939B (en) Industrial production process for cis-form propiconazole crude medicament
CN115124441B (en) Preparation method of No Bo Suan hydrazide compound, product and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant